Tumor Volume Changes on 1.5 Tesla Endorectal MRI During Neoadjuvant Androgen Suppression Therapy for Higher-Risk Prostate Cancer and Recurrence in Men Treated Using Radiation Therapy Results of the Phase II CALGB 9682 Study

Article ID	Journal	Published Year	Pages	File Type
8238972	International Journal of Radiation OncologyBiologyPhysics	2008	7 Pages	PDF

Abstract

Eradicating intraprostatic hormone refractory prostate cancer (HRPC) by maximizing local control and randomized trials assessing whether survival is improved when agents active against HRPC are combined with maximal local therapy are needed in men who progress based on eMRI during nAST.

Keywords

Magnetic resonance imaging Androgen suppression therapy Prostate cancer Radiation therapy

Related Topics

Physical Sciences and Engineering Physics and Astronomy Radiation

Preview

Tumor Volume Changes on 1.5 Tesla Endorectal MRI During Neoadjuvant Androgen Suppression Therapy for Higher-Risk Prostate Cancer and Recurrence in Men Treated Using Radiation Therapy Results of the Phase II CALGB 9682 Study

Authors

Anthony V. M.D., Ph.D., Susan Ph.D., Clare M.D., David M.D., George K. M.D., M.B.B.S., M.P.H., Marian R.N., O.C.N., Elizabeth R.N., Ben M.S., Nicholas J. M.D., Eric J. M.D., Cancer and Leukemia Group B Cancer and Leukemia Group B,